Showing results (1301-1310 of 1,823) with videos related to
Sort By:
Pageof 183
Transplantation and Cellular Therapy|March 16, 2026
Ferritin as a pre-transplant biomarker for post-transplant outcomes in allogeneic stem cell transplantation using post-transplant cyclophosphamideSergio Rodriguez-Rodriguez, Caden Chiarello, Nihar Desai, et al.Transplantation and Cellular Therapy|April 1, 2026
Prognostic Impact of BK Polyomavirus Viremia Detected by Multiplex Plasma PCR Following Allogeneic Hematopoietic Cell TransplantationRyo Hasunuma, Hiroaki Shimizu, Daichi Sadato, et al.Transplantation and Cellular Therapy|March 27, 2026
CAR-T therapy-associated infections in hematologic malignancies: a real-world pharmacovigilance analysisXiangyang Ding, Kexin Ai, Suwan Wu, et al.Transplantation and Cellular Therapy|March 25, 2026
Fear of cancer recurrence in hematopoietic cell transplantation survivors: fear of cancer recurrence in HCT survivorsEmily C Liang, Megan J Shen, Rachel B Salit, et al.Transplantation and Cellular Therapy|March 29, 2026
Gene therapy for sickle cell disease: Practice recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene TherapyAkshay Sharma, Adetola Kassim, Alexis Thompson, et al.Transplantation and Cellular Therapy|April 13, 2026
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 AlterationsMoataz Ellithi, Sandeep Raj, Maria Bromberg, et al.Transplantation and Cellular Therapy|May 4, 2026
Third-Party Viral Specific T cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCTStella M Davies, Emily Blyth, Catherine M Bollard, et al.Transplantation and Cellular Therapy|April 28, 2026
Early initiation of defibrotide is associated with better survival in sinusoidal obstruction syndrome/veno-occlusive disease in adults: experience from two Canadian centersNihar Desai, Jean-François Tourigny, Carol Chen, et al.Transplantation and Cellular Therapy|April 19, 2026
Efficacy of Low-Dose Olanzapine for the Prevention of Conditioning Therapy-Induced Nausea and Vomiting in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationKanae Yamashita, Kimimori Kamijo, Yoshimitsu Shimomura, et al.Transplantation and Cellular Therapy|April 19, 2026
Fecal Microbiota Transplantation for gastrointestinal complications after Allogeneic Hematopoietic Cell Transplantation: a systematic review and narrative synthesisShan Liu, Zicong Huang, Zhi GuoPageof 183